Sable Investments

Sable Investments appears to be a private investment firm rather than a drug-development biotech or pharmaceutical operating company. Publicly available information ties it to healthcare-related investing, including a partnership with Montecito Medical in the acquisition of the Tennessee Oncology Proton Center in Franklin, Tennessee. Third-party databases also classify Sable Investments as an investor or venture capital firm, but there is little evidence of an operating therapeutics pipeline, proprietary drug platform, or internal clinical-stage assets. Based on available sources, the firm is best characterized as a healthcare-adjacent investment entity with exposure to medical real estate and selective private investments.